Prophylactic use of norvancomycin-heparin flushing for central venous catheter related infection

CLINICAL FOCUS ›› 2009, Vol. 24 ›› Issue (11): 935-937.

Previous Articles Next Articles

Prophylactic use of norvancomycin-heparin flushing for central venous catheter related infection

ZHOU Qing-ming;YANG Xiu-fen;WANG Chun-ling;ZHAO Li-min;ZHANG Zheng;TIAN Hui-yu

Online:2009-06-05 Published:2009-06-05

Abstract

CLC Number:

R378

ZHOU Qing-ming;YANG Xiu-fen;WANG Chun-ling;ZHAO Li-min;ZHANG Zheng;TIAN Hui-yu. Prophylactic use of norvancomycin-heparin flushing for central venous catheter related infection[J]. CLINICAL FOCUS, 2009, 24(11): 935-937.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2009/V24/I11/935

[1]	Wang Yue;Shi Like;Zhang Lutao;Wang Shibo;Wang Liyi;Jia Yuan;Dong Xing. Distribution of pathogens and resistance analysis of hospital-acquired lower respiratory tract infection [J]. Clinical Focus, 2015, 30(11): 1269-1272.
[2]	Guo Jiahong;Wang Wensheng;Zhou Jinghua;Yan Donghui. Clinical distribution and antibiotic resistance of 205 strains of Stenotrophomonas maltophilia [J]. Clinical Focus, 2015, 30(1): 60-63.
[3]	TONG Yu-hong;ZHENG Ying;QIAN Xue-song;WANG Xin;ZHANG Jin-liang;LIU Bing-hui;XING Jiang-tao. Regulation of B7-H2 expression in type Ⅱ epithelial cells of lung by tuberculosis bacili H37Ra [J]. Clinical Focus, 2014, 29(8): 899-902961.
[4]	PEI De-cui;XIONG Chuan-yin;BI Ai-fen;HU Han-bin. Apoptosis related genes expressed in human umbilical vein endothelial cells infected with Staphylococcus aureus [J]. Clinical Focus, 2014, 29(7): 751-753754.
[5]	WEI Wei;QIN Lin-zhen;LIU Shou-jiang;WANG Jian. Clinical value of real-time fluorescence polymerase chain reaction for Mycobacterium tuberculosis DNA in bronchoalveolar lavage fluid [J]. Clinical Focus, 2014, 29(6): 611-613.
[6]	SONG Su-jing;SHU Jing;MA Chun-hui;WU Jiang-li;LI Li-hua;ZHOU Chun-ying;FAN Shu-ping;SONG Shu-xia. Interleukin-4 and interleukin-17A detection in mycobacterium tuberculosis infection patients [J]. Clinical Focus, 2014, 29(6): 624-626.
[7]	. [J]. CLINICAL FOCUS, 2013, 28(7): 806-808.
[8]	. [J]. Clinical Focus, 2012, 27(14): 1247-1248.
[9]	YU Hai-dong;XIN Hua;WANG Ying;ZHANG Wen-lu;WANG Yong;MA Lei;YANG Hui. Genotype distribution of plasmid-mediated AmpC β-lactamases,extended-spectrum β-Iactamase among Escherichia coli and Enterobacter cloacae isolates in Jiamusi [J]. Clinical Focus, 2012, 27(11): 946-949.
[10]	QIN Jin-xi;LI Zhong-xing;YUAN Xin;BAI Xiu-ju;SHI Xin-luo. Study of in vitro inhibitory activity of antibacterial material of Pseudomonas aeruginosa against Candida glabratas [J]. Clinical Focus, 2012, 27(7): 574-0.
[11]	. [J]. CLINICAL FOCUS, 2011, 26(19): 1704-1706.
[12]	. [J]. Clinical Focus, 2011, 26(17): 1534-1536.
[13]	FENG Qing-li;YAO Ai-qin;DANG Yu-hua . Study on relationship between coronary atherosclerosis and D-dimer,large artery elasticity [J]. CLINICAL FOCUS, 2011, 26(14): 1207-1210.
[14]	WANG Xiao-ni;WEI Dian-jun. Antimicrobial resistance in Shigella spp and based on ERIC typing character crossing two decades in Tianjin [J]. CLINICAL FOCUS, 2011, 26(9): 775-778.
[15]	HOU Yuan-pei;PENG Su-zhen;PENG Yun-li;LIU Cheng-yong. Drug resistance of Mycobacterium tuberculosis in an epidemiological survey in Xuzhou [J]. CLINICAL FOCUS, 2011, 26(8): 666-668.

Prophylactic use of norvancomycin-heparin flushing for central venous catheter related infection

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments